Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities

R Pivonello, RS Auriemma, LFS Grasso, C Pivonello… - Pituitary, 2017 - Springer
Acromegaly is associated with an enhanced mortality, with cardiovascular and respiratory
complications representing not only the most frequent comorbidities but also two of the main …

Cardiovascular involvement in patients affected by acromegaly: an appraisal

S Mosca, S Paolillo, A Colao, E Bossone… - International journal of …, 2013 - Elsevier
Cardiovascular complications are frequent in acromegalic patients. Several studies reported
increased prevalence of traditional cardiovascular risk factors and early development of …

Acromegaly, inflammation and cardiovascular disease: a review

TLC Wolters, MG Netea, NP Riksen… - Reviews in Endocrine …, 2020 - Springer
Acromegaly is characterized by Growth Hormone (GH) and Insulin-like Growth Factor 1 (IGF-
1) excess. Uncontrolled acromegaly is associated with a strongly increased risk of …

The risks of overlooking the diagnosis of secreting pituitary adenomas

T Brue, F Castinetti - Orphanet journal of rare diseases, 2016 - Springer
Secreting pituitary adenomas that cause acromegaly and Cushing's disease, as well as
prolactinomas and thyrotroph adenomas, are uncommon, usually benign, slow-growing …

Hypertension and acromegaly

S Puglisi, M Terzolo - Endocrinology and Metabolism Clinics, 2019 - endo.theclinics.com
Acromegaly is a rare, chronic disease whose clinical manifestations are the consequence of
growth hormone (GH) and insulinlike growth factor (IGF) 1 excess that is usually caused by a …

The endothelium in acromegaly

P Maffei, F Dassie, A Wennberg, M Parolin… - Frontiers in …, 2019 - frontiersin.org
Growth hormone (GH) and insulin like growth factor-1 (IGF-1) excess induce well-known
deleterious effects on the cardiovascular system, especially after long-term exposition …

Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis

M Parolin, F Dassie, C Martini, R Mioni, L Russo… - Pituitary, 2018 - Springer
Objective Multiple studies investigated preclinical markers of peripheral vascular damage in
acromegaly (ACRO) reporting discordant results. The aim of this study was to run a meta …

Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly

C Ozkan, AE Altinova, ET Cerit, C Yayla, A Sahinarslan… - Pituitary, 2015 - Springer
Purpose Data regarding atherosclerosis in acromegaly is controversial in literature. We
aimed to investigate the markers of early atherosclerosis, oxidative stress, inflammation and …

Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors

M Yaron, E Izkhakov, J Sack, I Azzam, E Osher… - Pituitary, 2016 - Springer
Purpose Acromegaly is associated with increased cardiovascular morbidity and mortality
when inadequately treated, which may be secondary to associated comorbidities or to direct …

Should Cushing's syndrome be considered as a disease with high cardiovascular risk in relevant guidelines?

G Koracevic, M Stojkovic, D Lovic… - Current Vascular …, 2020 - ingentaconnect.com
A considerable amount of data supports a 1.8-7.4-fold increased mortality associated with
Cushing's syndrome (CS). This is attributed to a high occurrence of several cardiovascular …